Total Payments
$928,523
2024 Payments
$33,076
Companies
64
Transactions
2,057
Medicare Patients
1,221
Medicare Billing
$199,319
Payment Breakdown by Category
Other$685,125 (73.8%)
Travel$147,983 (15.9%)
Consulting$51,741 (5.6%)
Food & Beverage$43,441 (4.7%)
Education$233.13 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $672,605 | 312 | 72.4% |
| Travel and Lodging | $147,983 | 250 | 15.9% |
| Consulting Fee | $51,741 | 24 | 5.6% |
| Food and Beverage | $43,441 | 1,452 | 4.7% |
| Honoraria | $12,520 | 6 | 1.3% |
| Education | $233.13 | 13 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $474,851 | 583 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $180,985 | 203 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $109,077 | 180 | $0 (2024) |
| Corcept Therapeutics | $91,301 | 186 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $35,498 | 67 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $10,508 | 31 | $0 (2024) |
| Lilly USA, LLC | $4,668 | 81 | $0 (2024) |
| ABBVIE INC. | $3,191 | 72 | $0 (2024) |
| Novo Nordisk AS | $2,892 | 8 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,198 | 17 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $33,076 | 178 | Novo Nordisk Inc ($18,833) |
| 2023 | $23,769 | 178 | Corcept Therapeutics ($12,977) |
| 2022 | $109,329 | 233 | Novo Nordisk Inc ($67,247) |
| 2021 | $105,274 | 255 | Novo Nordisk Inc ($73,824) |
| 2020 | $89,448 | 206 | Novo Nordisk Inc ($49,224) |
| 2019 | $133,111 | 285 | Novo Nordisk Inc ($72,241) |
| 2018 | $202,214 | 356 | Novo Nordisk Inc ($95,744) |
| 2017 | $232,302 | 366 | Janssen Pharmaceuticals, Inc ($104,488) |
All Payment Transactions
2,057 individual payment records from CMS Open Payments — Page 1 of 83
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: Automated insulin delivery system | ||||||
| 12/18/2024 | Corcept Therapeutics | Korlym (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Endocrinology | ||||||
| 12/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: Diabetes Care | ||||||
| 12/17/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $24.13 | General |
| Category: Insulin Pump | ||||||
| 12/16/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Endocrinology | ||||||
| 12/12/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $113.02 | General |
| Category: Endocrinology | ||||||
| 12/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Endocrinology | ||||||
| 12/09/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $31.15 | General |
| 12/04/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $7.12 | General |
| Category: Insulin Pump | ||||||
| 12/03/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: Diabetes Care | ||||||
| 11/26/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Endocrinology | ||||||
| 11/22/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $29.09 | General |
| Category: Automated insulin delivery system | ||||||
| 11/21/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/20/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $31.86 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/19/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $59.51 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/18/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $2.43 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/14/2024 | Novo Nordisk Inc | Tresiba (Drug), Rybelsus, Ozempic | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 350 | 784 | $149,445 | $55,158 |
| 2022 | 4 | 337 | 755 | $111,920 | $52,253 |
| 2021 | 2 | 270 | 709 | $73,400 | $47,710 |
| 2020 | 2 | 264 | 655 | $67,575 | $44,198 |
Total Patients
1,221
Total Services
2,903
Medicare Billing
$199,319
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 213 | 573 | $126,060 | $45,882 | 36.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 53 | $8,215 | $3,128 | 38.1% |
| 99091 | Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | Office | 2023 | 33 | 79 | $7,900 | $2,982 | 37.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 36 | $4,320 | $2,119 | 49.1% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 41 | 43 | $2,950 | $1,046 | 35.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 236 | 637 | $100,580 | $47,325 | 47.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 52 | $6,060 | $2,680 | 44.2% |
| 99091 | Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | Office | 2022 | 30 | 33 | $3,300 | $1,377 | 41.7% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 25 | 33 | $1,980 | $870.33 | 44.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 240 | 673 | $70,700 | $45,893 | 64.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 30 | 36 | $2,700 | $1,817 | 67.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 228 | 615 | $64,575 | $42,691 | 66.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 36 | 40 | $3,000 | $1,507 | 50.2% |
About Dr. Terri Jerkins, M.D
Dr. Terri Jerkins, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538147319.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Terri Jerkins, M.D has received a total of $928,523 in payments from pharmaceutical and medical device companies, with $33,076 received in 2024. These payments were reported across 2,057 transactions from 64 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($672,605).
As a Medicare-enrolled provider, Jerkins has provided services to 1,221 Medicare beneficiaries, totaling 2,903 services with total Medicare billing of $199,319. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Nashville, TN
- Active Since 01/03/2006
- Last Updated 08/07/2025
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1538147319
Products in Payments
- Ozempic (Drug) $183,290
- INVOKANA (Drug) $180,858
- Korlym (Drug) $91,301
- FARXIGA (Drug) $85,908
- Tresiba (Drug) $77,982
- RYBELSUS (Drug) $67,010
- Rybelsus (Drug) $49,522
- Victoza (Drug) $41,598
- Kerendia (Drug) $35,498
- Xultophy 100/3.6 (Drug) $23,439
- BYDUREON (Drug) $23,169
- JARDIANCE (Drug) $14,163
- Synthroid (Drug) $2,346
- CYCLOSET (Drug) $2,237
- Omnipod (Device) $1,333
- Repatha (Biological) $1,162
- FREESTYLE LIBRE 3 (Device) $651.02
- TZIELD (Biological) $564.09
- Dexcom G6 Transmitter (Medical Supply) $459.93
- iLet Bionic Pancreas (Device) $422.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Nashville
Craig Wierum, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.6M
Endocrinology, Diabetes & Metabolism $1.6M
Mr. Michael Carlson, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $481,267
Endocrinology, Diabetes & Metabolism $481,267
Kathryn Dahir, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $233,707
Endocrinology, Diabetes & Metabolism $233,707
Rodney Snow, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $121,382
Endocrinology, Diabetes & Metabolism $121,382
Cheryl Fassler, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $46,992
Endocrinology, Diabetes & Metabolism $46,992
Dr. Jon Levine, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $33,653
Endocrinology, Diabetes & Metabolism $33,653